Literature DB >> 9204012

Management of cystic fibrosis before and after lung transplantation.

J J Egan1, A A Woodcock, A K Webb.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9204012      PMCID： PMC1296099          DOI： 10.1177/014107689709031S10

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  46 in total

1.  Impairment of bronchial mucociliary clearance in long-term survivors of heart/lung and double-lung transplantation. The Paris-Sud Lung Transplant Group.

Authors:  P Herve; D Silbert; J Cerrina; G Simonneau; P Dartevelle
Journal:  Chest       Date:  1993-01       Impact factor: 9.410

2.  Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital.

Authors:  C Dennis; N Caine; L Sharples; R Smyth; T Higenbottam; S Stewart; T Wreghitt; S Large; F C Wells; J Wallwork
Journal:  J Heart Lung Transplant       Date:  1993 Nov-Dec       Impact factor: 10.247

3.  Non-Hodgkin lymphoma in heart/lung transplant recipients.

Authors:  J Egan; J Stewart; N Yonan; J Arrand; A Woodcock
Journal:  Lancet       Date:  1994-02-19       Impact factor: 79.321

4.  Resting energy expenditure. Evolution during antibiotic treatment for pulmonary exacerbation in cystic fibrosis.

Authors:  H Naon; S Hack; M T Shelton; R C Gotthoffer; D Gozal
Journal:  Chest       Date:  1993-06       Impact factor: 9.410

5.  Clinical features of Pseudomonas cepacia pneumonia in an epidemic among immunocompromised patients.

Authors:  Y Yamagishi; J Fujita; K Takigawa; K Negayama; T Nakazawa; J Takahara
Journal:  Chest       Date:  1993-06       Impact factor: 9.410

6.  Upper gastrointestinal dysmotility in heart-lung transplant recipients.

Authors:  J Au; T Hawkins; C Venables; G Morritt; C D Scott; A D Gascoigne; P A Corris; C J Hilton; J H Dark
Journal:  Ann Thorac Surg       Date:  1993-01       Impact factor: 4.330

7.  Heart-lung transplantation in cystic fibrosis: predictions for the next decade in England and Wales.

Authors:  J S Elborn; D J Shale; J R Britton
Journal:  Respir Med       Date:  1994-02       Impact factor: 3.415

8.  Pseudomonas cepacia in lung transplant recipients with cystic fibrosis.

Authors:  G I Snell; A de Hoyos; M Krajden; T Winton; J R Maurer
Journal:  Chest       Date:  1993-02       Impact factor: 9.410

9.  A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation.

Authors:  J D Cooper; M Billingham; T Egan; M I Hertz; T Higenbottam; J Lynch; J Mauer; I Paradis; G A Patterson; C Smith
Journal:  J Heart Lung Transplant       Date:  1993 Sep-Oct       Impact factor: 10.247

10.  Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients.

Authors:  G Opelz; R Henderson
Journal:  Lancet       Date:  1993 Dec 18-25       Impact factor: 79.321
View more
  1 in total

1.  Practical guidelines: lung transplantation in patients with cystic fibrosis.

Authors:  T O Hirche; C Knoop; H Hebestreit; D Shimmin; A Solé; J S Elborn; H Ellemunter; P Aurora; M Hogardt; T O F Wagner
Journal:  Pulm Med       Date:  2014-03-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.